Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial-Reference-Cited by-同舟云学术

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial

Published:2024-04 Issue:4 Volume:9 Page:333-345
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Lindsay James O,Hind Daniel,Swaby Lizzie,Berntsson Hannah,Bradburn Mike,Bannur C Uday,Byrne Jennifer,Clarke Christopher,Desoysa Lauren,Dickins Ben,Din Shahida,Emsley Richard,Foulds Gemma A,Gribben John,Hawkey Christopher,Irving Peter M,Kazmi Majid,Lee Ellen,Loban Amanda,Lobo Alan,Mahida Yashwant,Moran Gordon W,Papaioannou Diana,Parkes Miles,Peniket Andrew,Pockley A Graham,Satsangi Jack,Subramanian Sreedhar,Travis Simon,Turton Emily,Uttenthal Ben,Rutella Sergio,Snowden John A

Funder

NIHR

Publisher

Elsevier BV

Reference41 articles.

1. Crohn's disease;Torres;Lancet,2017

2. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study;van der Valk;Gut,2014

3. Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn's disease: systematic review and network meta-analysis;Barberio;Gut,2023

4. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial;Stevens;Lancet Gastroenterol Hepatol,2020

5. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial;Burt;JAMA,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophosphamide-free Mobilisation Increases Safety While Preserving the Efficacy of Autologous Haematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease Patients;Journal of Crohn's and Colitis;2024-05-17

2. Haematopoietic stem-cell transplantation for patients with Crohn's disease: primum non nocere;The Lancet Gastroenterology & Hepatology;2024-04